UT HEALTH EMERGENCY MEDICINE & TRAUMA GUIDELINES

Similar documents
Spiders and Snakes Martin Belson, MD

Spencer Greene, MD, MS, FACEP, FACMT

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

By the end of this lecture students will be able to understand Importance, epidemiology, pathogenesis of snake bite Clinical manifestations

STATE TOXINOLOGY SERVICES Toxinology Dept., Women s & Children s Hospital, North Adelaide SA 5006 AUSTRALIA

5 Dangerous Venom Types Thailand Snakes. Thailand Snake Venom Types:

STANDARDS of CARE. There are two groups of venomous snakes in North EMERGENCY AND CRITICAL CARE MEDICINE CROTALID ENVENOMATIONS

Clinical Profile of Envenomation in Children With Reference To Snake Bite

Who am I? Who am I? Rattlesnake Envenomations and more. CAPA 2015 Annual Conference. Travis Martois PA-C CAPA Conference 10/11/2015

SNABIRC-KENYA A GUIDE TO MANAGING SNAKEBITES

Clinical Features, Management and Outcome of Snake Bite in Children in Manipal Teaching Hospital

Neutralization of Micrurus distans distans venom by antivenin (Micrurus fulvius)

Snakes on the Plain. Copperhead. By Brooke Cain

Snake-Bite Present Scenario In Bangladesh. Dr A K M Humayon Kabir Associate professor Dept. of Medicine Dhaka Medical College

Fish Envenomation. Tony Alleman, MD MPH FACOEM UHM

Appendix: Outcomes when Using Adjunct Dexmedetomidine with Propofol Sedation in

Venomous Snakes of Northeast Florida. Del Webb Men s Club October 22, 2015

6/20/2018. A Public Benefit Corporation. A First-in-Class Snakebite Antidote. Discovery to Accelerated Development

Bites and Stings Snakes, Spiders, and Scorpions in the United States

DOWNLOAD OR READ : SNAKE BITE PDF EBOOK EPUB MOBI

STANDARDS of CARE. Venomous snakes inhabit every region of the EMERGENCY AND CRITICAL CARE MEDICINE PIT VIPER ENVENOMATION IN DOGS

WHO/SEARO GUIDELINES FOR THE CLINICAL MANAGEMENT OF SNAKE BITES IN THE SOUTHEAST ASIAN REGION

Large Snake Size Suggests Increased Snakebite Severity in Patients Bitten by Rattlesnakes in Southern California

SNAKE ENVENOMATION. RYAN DE VOE DVM, MSpVM, DACZM, DABVP-Avian. Modified by Michael R.Loomis, DVM, MA, DACZM North Carolina Zoological Park

Mojave rattlesnake envenomation in southern California: A review of suspected cases

An informational newsletter

Envenomation by the hump nosed viper (hypnale hypnale) in children: a pilot study

CLINICAL ESSENTIAL HUDDLE CARD. All associates must comply with their state practice acts.

Venomous Snakes in Florida: Identification and Safety

Delayed reporting to health care facilities: a significant determinant of fatalities in cases of snake bites

2/13/2014. Rais Vohra MD UCSF Fresno Medical Center California Poison Control System

Common Viper Bites in the Czech Republic Epidemiological and Clinical Aspects during 15 Year Period ( )

66 ISSN East Cent. Afr. J. surg

Snake Bite Kit Caution!

Contributors T A B L E O F C O N T E N T S

PHYSICIAN ORDERS. Page 1 of 6. Provider Initial: Esophagectomy Preoperative [ ] Height Weight Allergies

Venomous snakes can be found throughout most of the

Providing Public Health Recommendations to Clinicians for Rabies Post Exposure Prophylaxis. Fall 2014

Management of Snake Bite in Saudi Arabia

Rattlesnake Envenoming Therapies

Joint Trauma System. Bites, Stings, and Envenomation

Approximately 45,000 snakebite

VENOM WEEK 2005 (Formerly "Snakebites in the New Millenium: A State-of-the-Art-Symposium" Friday, October 21, 2005: Field Trip, Introductions and

Venomous Snakebite in Mountainous Terrain: Prevention and Management

Clinical Manifestations and Treatment of Plague Dr. Jacky Chan. Associate Consultant Infectious Disease Centre, PMH

Scottish Surveillance of Healthcare Infection Programme (SSHAIP) Health Protection Scotland SSI Surveillance Protocol 7th Edition 2017 Question &

Period of study: 12 Nov 2002 to 08 Apr 2004 (first subject s first visit to last subject s last visit)

(D) fertilization of eggs immediately after egg laying

Snakebites of fingers or toes by Viperidae family members : An orthopaedic approach

Propofol vs Dexmedetomidine

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

Iowa State University Institutional Animal Care and Use Committee (IACUC)

NUMBER: /2005

July/August Joe McDonald

Materials and Methods: Anti-snake venom activities of Asparagus racernosus

Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients

When to Call a Pediatric Surgeon. Kim Ruscher Wife, Mom, Pediatric Surgeon

NUMBER: R&C-ARF-10.0

Please call the Pharmacy Medicines Unit on or for a copy.

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

Traveling Treasures 2016 The Power of Poison

Clinical Practice Guidelines

The above question was submitted to four authorities and the following replies were received:

SNAKEBITE MANAGEMENT: Experiences From Gulu Regional Hospital Ugandz

Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC

2/5/2016. Military Tourniquet PFN:SOMTRL0B. Terminal Learning Objective. Reason. Hours: 0.5

VENOMOUS SNAKE BITES IN LAO PDR: A RETROSPECTIVE STUDY OF 21 SNAKEBITE VICTIMS IN A PROVINCIAL HOSPITAL

Hendra virus: Important information for all horse owners. An update on Hendra virus The Hendra vaccine

Methods. Objective. Results

We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to

3 RD INTERNATIONAL SUMMIT ON TOXICOLOGY & APPLIED PHARMACOLOGY OCTOBER 20-22, 2014 CHICAGO, USA

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

Welcome! 10/26/2015 1

Anesthesia Check-off Form

Animal Bites CHAPTER INTRODUCTION GENERAL. Scene Safety and Preplanning. Jeffrey D. Ferguson

Keeping Pets Safe from Desert Dangers Dr. Heather E. Connally, DVM, MS, Diplomate American College of Veterinary Emergency and Critical Care

SNAKE BITE; FREQUENCY OF VARIOUS CLINICAL PRESENTATIONS OF ADMITTED PATIENTS AND AVERAGE TIME TO REACH HOSPITAL

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

Clinical Profile and Outcome of Envenomous Snake-Bite At Tertiary Care Centre In Nellore- A Retrospective Study

SAFETY PROTOCOLS FOR WORKING WITH VENOMOUS SNAKES SOUTHEASTERN

Regional vs Systemic Antivenom Administration in the Treatment of Snake Venom Poisoning in a Rabbit Model: A Pilot Study

Clinical profile and outcome of snake bite in children

MANAGEMENT OF DOMESTIC ANIMAL RABIES EXPOSURES NEW JERSEY DEPARTMENT OF HEALTH March 2016

Linda Laskowski Jones, MS, RN, ACNS-BC, CEN, FAWM

Avoiding Snakes and Spiders

Clinical Profile of Snake Bite in Children in Rural India. Vinayak Y. Kshirsagar, MD; Minhajuddin Ahmed, MD; Sylvia M.

Double-Blind, Placebo-Controlled, Randomized Study of Dipyrone as a Treatment for Pyrexia in Horses

PHARMACIST CLINICIAN:

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE

Feline blood transfusions: preliminary considerations

TETANUS OVERVIEW CLINICAL CASE: LB CLINICAL CASE: LB CLINICAL CASE: LB

Venomous Snake Bite Injuries at Kitui District Hospital

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

Pain Management in Racing Greyhounds

TELAZOL (tiletamine and zolazepam for injection) IV Induction Claim FAQs 1, 2

ESSENTIAL HEARTWORM PREVENTION GUIDE PROTECT YOUR DOG FROM HEARTWORM WITHOUT HARMFUL MEDS INFORMATION PROVIDED BY PETER DOBIAS DVM

THIS PATIENT GROUP DIRECTION HAS BEEN APPROVED on behalf of NHS Fife by:

Alfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS

Snake bites in north east Sri Lanka

Transcription:

UT HEALTH EMERGENCY MEDICINE & TRAUMA GUIDELINES TITLE: Snake bites ORIGINAL DATE: 07/2003 SUPERCEDES: 07/2013 LAST REVIEW DATE: 06/2017 Purpose Statement: To provide guidance on the evaluation and management of snakebites in the Houston area. Contacts: Poison Control Center 1-800-222-1222 The herpetologists at the Houston Zoo are available to help in the identification of snakes. 1. Judith Bryja Herpetology Supervisor Office 713-533-6655 (7am-7pm) 2. Herpetology Curator Office 713 533-6527 (7am-7pm) 3. Houston Zoo Operator Number (afterhours, emergency) Operator 713-533-6500 Antivenin for Rattlesnake, Copperhead and Water Moccasin Crofab (Protherics; Ovine-derived polyvalent Fab-1 antibody) Antivenin for Coral Snakes Coralmyn Available at Houston Zoo, not approved by FDA *additional consent for usage must be signed Antivenin for Exotic Snakes

Not readily available. Contact the poison control center for assistance. They will assist in obtaining antivenin if the snake is not found in the Houston Zoo collection. *additional consent for usage must be signed If the victim has a personal supply of antivenin for the type of snake involved, it can be used if it is not visibly turbid or expire/ five or fewer years beyond its expiration date. Identification of Snakes: There are four classes of poisonous snakes in the Houston area; Rattlesnake, Copperhead, Water Moccasin, and Coral. 1. Coral snakes are easily identified due to their bright colors. Corral snakes in the United States are poisonous if the color red touches yellow. Red on black are not native poisonous snakes to the U.S. This general principle reliably applies only to coral snakes native to North America. 2. Rattlesnakes, Copperheads, and Water Moccasins can be difficult to identify. If question is raised to weather the snake is poisonous some principles can be taken to identify poisonous verses non-poisonous. (Figure 1) 3. Exotic snakes: Identification of the snake is of key importance in providing appropriate care as envenomation by some of these snakes requires a specific antivenin. If at all possible, a herpetologist should see the snake or a high quality photograph of the snake in order to identify the snake as precisely as possible. (See contact information above). Rattlesnake, Copperhead or Water Moccasin Management 1. Attend to ABC s 2. Obtain the following labs a. CBC b. TEG 3. Depending upon the circumstances, consider the following: a. BMP, Liver profile, UA b. EKG Older adults and those with known heart disease c. CPK Patients with significant local edema d. PT/PTT, INR, FSP, Fibrinogen (Poison control follows) e. Type and Cross Those with significant coagulopathy f. ETOH/UDS Intoxication is common among a certain sub-group of victim g. Consider an x-ray of the bite site to rule out a retained fang or fragment thereof. 4. Mark and track the spread of erythema/ swelling on the patient s skin, along with time. 5. Tetanus prophylaxis, if indicate 6. Antibiotics not needed. 7. Antivenin- Crofab Rattlesnake, Copperhead and Water Moccasin Antivenin Administration

Categorize the snake bite by the Snake Severity Score (Figure 2) as minimal, moderate, or severe and follow the Crofab Algorithm (Figure 3). Administer the first portion of the antivenin slowly over 10 minutes. If no adverse effects occur, continue administration so that the initial 4-6 vials are administered over 1 hour. Rattlesnake, Copperhead and Water Moccasin Disposition If admission is warranted consult Trauma for adult patients. Pediatric patients (<16 years age) should have a Pediatric Trauma consult. 1. The following patients should be placed in the ICU or IMU per discretion of the trauma/pediatric trauma team. a. Patients with systemic symptoms even if the symptoms resolved with the administration of antivenin. b. Patients with active bleeding and coagulopathy. c. Patients with grossly abnormal coagulation indices. d. Patients requiring antivenin. 2. Documented compartment syndrome should be admitted to Trauma/Pediatric Trauma with Orthopedic or Hand service consult as needed. 3. If mild envenomation, placement in observation under the hospitalist/general pediatrics is appropriate. Trauma/Pediatric Trauma should be aware in case patient condition worsens. 4. Presumed dry bites or patients with none of the above criteria that still require short term observation should be placed in the COU under Hospitalist or Pediatric Observation with General Pediatrics. 5. If no swelling, ecchymosis, abnormal labs or vitals and the ED attending deems appropriate, patient can be discharged with close follow up. Patients being discharged do not need a Trauma/Pediatric Trauma consult or follow-up in their surgery clinics. Coral Snake Management 1. Attend to ABC s 2. Consider elective tracheal intubation if any signs of bulbar paralysis are present. 3. Consider an EKG Anecdotal evidence suggests that coral snake envenomation is sometimes associated with cardiac arrhythmias. 4. Tetanus prophylaxis, if indicated. 5. Antibiotics not needed. 6. No specific laboratory tests are mandatory but the following might be considered especially in patients with underlying medical conditions: CBC, TEG, VBG and CMP. 7. Systemic effects may be delayed for many hours but can include: Impending respiratory failure, Respiratory distress, Pharyngeal spasm, Hypersalivation, Cyanosis, Trismus, Neurologic dysfunction, Altered mental status, Ptosis, Generalized weakness, Muscle fasciculations, Cardiovascular collapse, Hypotension, and Tachycardia. 8. If the snake is positively identified, antivenin should be administered presumptively in cases of envenomation. 9. Antivenin- Coralmyn. Coral Snake Antivenin Administration

1. The only FDA approved coral snake antivenin, Wyeth Micrurus, is no longer being produced and limited stock piles are now expired. 2. Alternative is antivenin called Coralmyn. It is manufactured in Mexico and is available in the US, however, not approved by the FDA approved. If needed it can be obtained from the Houston Zoo. Special consent must be signed if this is used. 3. Pretreat with diphenhydramine and H2 blocker. 4. Assure that airway devices, epinephrine, steroids, and other medications and equipment necessary to treat anaphylaxis are at the bedside. 5. To administer antivenin reconstitute the antivenin as directed on the package and follow instructions. 6. Begin a slow infusion while observing the patient for symptoms. If no reaction occurs after a few minutes of slow infusion, then the infusion rate may be increased so that the entire initial dose is administered over 1-2 hours. Coral Snake Disposition 1. Asymptomatic patients should be observed for 24 hours. Symptoms may be delayed in onset for up to 12 hours or more. Given the potentially lethal nature of coral snake venom, these patients should be admitted to Trauma/Pediatric Trauma for monitoring. 2. All patients with a good history for envenomation by a coral snake should be admitted to the ICU or IMU (per discretion of Trauma/Pediatric Trauma Attending) for at least 24 hours of monitoring. Exotic Snake Management Different species of snake and members of the same species from different environments have different qualities of venom. Toxins: Neurotoxin, Cardiotoxin, Nephrotoxin, Coagulotoxins, Myotoxins/Necrotoxins. 1. Attend to the ABC s 2. Be prepared to support ventilation should respiratory distress occur. 3. Contact the herpetologist to determine if offending snake is found in the Houston Zoo s collection. If so, they will have antivenin available. 4. Contact the poison control center for management advice. They can help to obtain antivenin, if the snake is not found in the Houston Zoo collection. Some types of antivenin are difficult to obtain and must come from other states. 5. If the victim has a personal supply of antivenin for the type of snake involved, it can be used if: a. Is not visibly turbid b. It is not expired or is five or fewer years beyond its expiration date Exotic Snake Disposition All patients bitten by non-native venomous snakes should be admitted to Trauma/Pediatric Trauma for further monitoring.

Appendix: Figure 1: US poisonous snake/pit viper identification Poisonous Non-poisonous

Figure 2: Snake Severity Score (Mild, Moderate, Severe)

Figure 3: Algorithm for Poisonous Snake Management and Disposition Attend to ABCs Identify the snake Copperhead, Water Moccasin, or Rattlesnakes Laboratory Studies Snake Severity Score Coral Snake or Exotic Snake Laboratory Studies Close Monitoring Consult Trauma/ Pediatric Trauma Minimal 0-3 Moderate 4-7 Severe >7 Admit ICU/IMU Re-Assess SSS at 2-hr including repeat TEG Administer loading dose of 4-6 vials of CroFab If Needed, place in Observation with Hospitalist/ General Pediatrics Re-examination; Repeat Coags n 6-8 hours Discharge when clinically stable Poisonous Snakebite Protocol Consult Trauma/Pediatric Trauma Admit ICU/IMU Re-Assess SSS Q2H including serial TEGs SSS stable or decreasing Maintenance Dose: 2 vials every 6 hours x 3 Assess Clinically and SSS/TEG every 6 hours Discharge when clinically stable SSS stable or decreasing SSS Increasing Repeat Loading Dose: of 4-6 vials SSS Increasing